Leadership
Intuitive Names Pfizer's Jeremy Forman VP, Head of Enterprise AI & Data
By News Desk ·
Key takeaways
- Jeremy Forman joined Intuitive as VP, Head of Enterprise AI & Data, bringing more than two decades of experience in AI, data strategy and enterprise architecture.
- Forman was most recently Chief AI, Data, & Analytics Officer at Pfizer and earlier served as Executive Director at Seagen.
- Intuitive promoted Taylor Patton to Chief Commercial and Marketing Officer in July 2026, succeeding Henry Charlton.
Jeremy Forman has been appointed VP, Head of Enterprise AI & Data at Intuitive, the Sunnyvale, California-based robotic-assisted surgery company, Hrtoday reported on November 4, 2026. Forman brings more than two decades of experience across artificial intelligence, data strategy, analytics, enterprise architecture, data governance, technology transformation and responsible AI.
Forman's Pfizer and Seagen Background
Forman joins Intuitive from Pfizer, where he most recently served as Chief AI, Data, & Analytics Officer. Earlier at Pfizer he was Vice President, Global R&D AI, Data, & Analytics, with work focused on AI transformation across research and development, including agentic AI, data integration, governance, responsible AI and enterprise-wide data capabilities.
Before Pfizer, Forman was Executive Director – AI & Data Strategy, Science, & Platforms at Seagen, where he led initiatives spanning AI innovation, data strategy, platform modernization and cross-functional alignment across R&D, commercial and operations. He also spent nearly eight years with the Bill & Melinda Gates Foundation, progressing from Chief Enterprise Architect to Director, Enterprise Architecture, Global Data & Analytics.
Earlier, Forman spent more than eight years with Oracle USA in leadership roles including Director – Enterprise Architecture North America, Senior Manager – Enterprise Architecture and Oracle Enterprise Architect. His earlier career includes technology and data roles with Los Alamos National Laboratory and the New Mexico Department of Transportation. He has also served as an Adjunct Lecturer in the Department of Business Analytics at The University of Iowa Tippie College of Business, teaching data leadership, data strategy, data management, security, privacy and the ethical use of data.
Intuitive's Recent Leadership and Platform Moves
According to akta.pro company records, Intuitive promoted Taylor Patton to Chief Commercial and Marketing Officer in July 2026, succeeding Henry Charlton, who transitions to Senior Vice President of Global Business Operations. The same records list Gary Guthart as Chief Executive Officer and Dave Rosa as President.
The company's installed base stood at 11,395 da Vinci systems globally, growing 12% year-over-year as of Q1 2026, and 1,041 Ion systems, up 22% year-over-year, according to the same records. Intuitive has recorded more than 14 million cumulative da Vinci procedures.
Earlier Intuitive Developments
In October 2026, Intuitive Fosun CEO Jason Liu said China's surgical robot market will be defined by ecosystem, not price, Yicaiglobal reported. The company had trained over 22,000 professionals and installed more than 510 da Vinci and Ion systems in China.
In June 2026, Intuitive partnered with Optellum and the NHS in the UK to integrate the LungOS AI platform with its Ion system within the lung cancer care pathway for peripheral lung biopsy, with Optellum deployed across more than 250 clinical sites, according to akta.pro company records. In April 2026, the company received FDA 510(k) clearance expanding five of six Force Feedback instruments from 6 to 15 uses per instrument.